Combined supplementation of folic acid and vitamin E diminishes diabetes-induced embryotoxicity in rats

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 76, Issue 6, 2006, Pages 483-490

  Gäreskog, Mattias ^a,b   Eriksson, Ulf J ^a   Wentzel, Parri ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Apoptosis; Diabetes in pregnancy; Embryopathy; Folic acid; Rat; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; FOLIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN BAX; PROTEIN BCL 2; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CROWN RUMP LENGTH; DIET SUPPLEMENTATION; EMBRYO; EMBRYOTOXICITY; FETUS MALFORMATION; FETUS RESORPTION; GEL MOBILITY SHIFT ASSAY; INTRAUTERINE GROWTH RETARDATION; MATERNAL DIABETES MELLITUS; MONOTHERAPY; NONHUMAN; OXIDATIVE STRESS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN CONTENT; RAT; SOMITE; VITAMIN SUPPLEMENTATION; WESTERN BLOTTING;

ABNORMALITIES; ANIMALS; CONGENITAL ABNORMALITIES; DIETARY SUPPLEMENTS; FEMALE; FETAL RESORPTION; FOLIC ACID; PREGNANCY; PREGNANCY IN DIABETICS; RATS; RATS, SPRAGUE-DAWLEY; VITAMIN E;

EID: 33748253096     PISSN: 15420752     EISSN: 15420760     Source Type: Journal    
DOI: 10.1002/bdra.20278     Document Type: Article

References (49)

1. Becerra JE, Khoury MJ, Cordero JF, Erickson JD. 1990. Diabetes mellitus during pregnancy and the risks for specific birth defects: a population-based case-control study. Pediatrics 85:1-9.
2. Berry RJ, Li Z, Erickson JD, et al. 1999. Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention. N Engl J Med 341:1485-1490.
3. Bojunga J, Nowak D, Mitrou PS, et al. 2004. Antioxidative treatment prevents activation of death-receptor- and mitochondrion-dependent apoptosis in the hearts of diabetic rats. Diabetologia 47: 2072-2080.
4. Catz SD, Johnson JL. 2001. Transcriptional regulation of bcl-2 by nuclear factor kappa B and its significance in prostate cancer. Oncogene 20: 7342-7351.
5. Cederberg J, Eriksson UJ. 1997. Decreased catalase activity in malformation-prone embryos of diabetic rats. Teratology 56:350-357.
6. Cederberg J, Siman CM, Eriksson UJ. 2001. Combined treatment with vitamin E and vitamin C decreases oxidative stress and improves fetal outcome in experimental diabetic pregnancy. Pediatr Res 49:755-762.
7. Cederberg J, Eriksson UJ. 2005. Antioxidative treatment of pregnant diabetic rats diminishes embryonic dysmorphogenesis. Birth Defects Res A Clin Mol Teratol 73:498-505.
8. Chen C, Edelstein LC, Gelinas C. 2000. The Rel/NF-kappaB family directly activates expression of the apoptosis inhibitor Bcl-x(L). Mol Cell Biol 20: 2687-2695.
9. Eriksson UJ, Dahlstrom E, Larsson KS, Hellerstrom C. 1982. Increased incidence of congenital malformations in the offspring of diabetic rats and their prevention by maternal insulin therapy. Diabetes 31:1-6.
10. Eriksson UJ, Borg LAH. 1991. Protection by free oxygen radical scavenging enzymes against glucose-induced embryonic malformations in vitro. Diabetologia 34:325-331.
11. Eriksson UJ, Borg LAH, Hagay Z, Groner Y. 1993. Increased superoxide dismutase (SOD) activity in embryos of transgenic mice protects from the teratogenic effects of a diabetic environment. Diabetes 42(Suppl 1): 85A (Abstract).
12. Eriksson UJ, Simán CM. 1996. Pregnant diabetic rats fed the antioxidant butylated hydroxytoluene show decreased occurrence of malformations in the offspring. Diabetes 45:1497-1502.
13. Forsberg H, Borg LAH, Cagliero E, Eriksson UJ. 1996. Altered levels of scavenging enzymes in embryos subjected to a diabetic environment. Free Radic Res 24:451-459.
14. Gareskog M, Wentzel P. 2004. Altered protein kinase C activation associated with rat embryonic dysmorphogenesis. Pediatr Res 56:849-857.
15. Goldman AS, Baker L, Piddington R, et al. 1985. Hyperglycemia-induced teratogenesis is mediated by a functional deficiency of arachidonic acid. Proc Natl Acad Sci USA 82:8227-8231.
16. Hawthorne G, Snodgrass A, Tunbridge M. 1994. Outcome of diabetic pregnancy and glucose intolerance in pregnancy: an audit of fetal loss in Newcastle General Hospital 1977-1990. Diabetes Res Clin Pract 25: 183-190.
17. Henderson GB, Suresh MR, Vitols KS, Huennekens FM. 1986. Transport of folate compounds in L1210 cells: kinetic evidence that folate influx proceeds via the high-affinity transport system for 5-methyltetrahydrofolate and methotrexate. Cancer Res 46(Pt 1):1639-1643.
18. Henderson GI, Perez T, Schenker S, et al. 1995. Materna 1-to-fetal transfer of 5-methyltetrahydrofolate by the perfused human placental cotyledon: evidence for a concentrative role by placental folate receptors in fetal folate delivery. J Lab Clin Med 126:184-203.
19. Honein MA, Paulozzi LJ, Mathews TJ, et al. 2001. Impact of folie acid fortification of the US food supply on the occurrence of neural tube defects. JAMA 285:2981-2986.
20. Ingold KU. 1961. Inhibition of the autoxidation of organic substances in the liquid phase. Chem Res Toxicol 61:563-589.
21. Kamen BA, Wang MT, Streckfuss AJ, et al. 1988. Delivery of folates to the cytoplasm of MA104 cells is mediated by a surface membrane receptor that recycles. J Biol Chem 263:13602-13609.
22. Kasibhatla S, Genestier L, Green DR. 1999. Regulation of fas-ligand expression during activation-induced cell death in T lymphocytes via nuclear factor kappaB. J Biol Chem 274:987-992.
23. Li R, Chase M, Jung SK, et al. 2005. Hypoxic stress in diabetic pregnancy contributes to impaired embryo gene expression and defective development by inducing oxidative stress. Am J Physiol Endocrinol Metab 289:E591-599.
24. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
25. Matsui K, Fine A, Zhu B, et al. 1998. Identification of two NF-kappa B sites in mouse CD95 ligand (Fas ligand) promoter: functional analysis in T cell hybridoma. J Immunol 161:3469-3473.
26. Metcalfe AD, Hunter HR, Bloor DJ, et al. 2004. Expression of 11 members of the BCL-2 family of apoptosis regulatory molecules during human preimplantation embryo development and fragmentation. Mol Reprod Dev 68:35-50.
27. Mills JL. 1982. Malformations in infants of diabetic mothers. Teratology 25: 385-394.
28. Moley KH, Chi MM, Knudson CM, et al. 1998. Hyperglycemia induces apoptosis in pre-implantation embryos through cell death effector pathways. Nat Med 4:1421-1424.
29. MRC. 1991. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet 338:131-137.
30. Pampfer S, de Hertogh R, Vanderheyden I, et al. 1990. Decreased inner cell mass proportion in blastocysts from diabetic rats. Diabetes 39: 471-476.
31. Papa S, Zazzeroni F, Bubici C, et al. 2004. Gadd45 beta mediates the NF-kappa B suppression of JNK signalling by targeting MKK7/JNKK2. Nat Cell Biol 6:146-153.
32. Penney GC, Mair G, Pearson DW. 2003. Outcomes of pregnancies in women with type 1 diabetes in Scotland: a national population-based study. BJOG 110:315-318.
33. Pham CG, Bubici C, Zazzeroni F, et al. 2004. Ferritin heavy chain upregulation by NF-kappaB inhibits TNFalpha-induced apoptosis by suppressing reactive oxygen species. Cell 119:529-542.
34. Phelan SA, Ito M, Loeken MR. 1997. Neural tube defects in embryos of diabetic mice: role of the Pax-3 gene and apoptosis. Diabetes 46:1189-1197.
35. Racek J, Rusnakova H, Trefil L, Siala KK. 2005. The influence of folate and antioxidants on homocysteine levels and oxidative stress in patients with hyperlipidemia and hyperhomocysteinemia. Physiol Res 54:87-95.
36. Sadler TW, Hunter ES, Wynn RE, Phillips LS. 1989. Evidence for multifactorial origin of diabetes-induced embryopathies. Diabetes 38:70-74.
37. Sato Y, Hotta N, Sakmoto N, et al. 1979. Lipid peroxide levels of plasma of diabetic patients. Biochem Med 21:104-107.
38. Simán CM, Eriksson UJ. 1997. Vitamin E decreases the occurrence of malformations in the offspring of diabetic rats. Diabetes 46:1054-1061.
39. Simmons CJ, Mosley BS, Fulton-Bond CA, Hobbs CA. 2004. Birth defects in Arkansas: is folic acid fortification making a difference? Birth Defects Res A Clin Mol Teratol 70:559-564.
40. Sivan E, Reece EA, Wu YK, et al. 1996. Dietary vitamin E prophylaxis and diabetic embryopathy: morphologic and biochemical analysis. Am J Obstet Gynecol 175:793-799.
41. Tamatani M, Che YH, Matsuzaki H, et al. 1999. Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NFkappaB activation in primary hippocampal neurons. J Biol Chem 274:8531-8538.
42. Tanaka H, Matsumura I, Ezoe S, et al. 2002. E2F1 and c-Myc potentiate apoptosis through inhibition of NF-kappaB activity that facilitates MnSOD-mediated ROS elimination. Mol Cell 9:1017-1029.
43. Traber MG. 1997. Regulation of human plasma vitamin E. Adv Pharmacol 38: 49-63.
44. Viana M, Herrera E, Bonet B. 1996. Teratogenic effects of diabetes mellitus in the rat Prevention with vitamin E. Diabetologia 39:1041-1046.
45. Wentzel P, Thunberg L, Eriksson UJ. 1997. Teratogenic effect of diabetic serum is prevented by supplementation of superoxide dismutase and N-acetylcysteine in rat embryo culture. Diabetologia 40:7-14.
46. Wentzel P, Eriksson UJ. 2005. A diabetes-like environment increases malformation rate and diminishes prostaglandin E(2) in rat embryos: reversal by administration of vitamin E and folic acid. Birth Defects Res A Clin Mol Teratol 73:506-511.
47. Wentzel P, Gareskog M, Eriksson UJ. 2005. Folic acid supplementation diminishes diabetes- and glucose-induced dysmorphogenesis in rat embryos in vivo and in vitro. Diabetes 54:546-553.
48. Woo M, Hakem R, Soengas MS, et al. 1998. Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes. Genes Dev 12:806-819.
49. Wu H, Lozano G. 1994. NF-kappa B activation of p53. A potential mechanism for suppressing cell growth in response to stress. J Biol Chem 269: 20067-20074.